↓ Skip to main content

Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.

Overview of attention for article published in Hormones international journal of endocrinology and metabolism, April 2016
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
79 Mendeley